Although the physiological role of this protein is still unknown [8], over-expression of MSLN is often observed in some types of human tumours, namely MPM (Malignant Pleural Mesothelioma), pancreatic and ovarian carcinomas [9]. Here, MSLN is linked to malignant pleural mesothelioma.